{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T02:51:02Z","timestamp":1682304662685},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T00:00:00Z","timestamp":1317254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s12020-011-9538-2","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T16:47:54Z","timestamp":1317228474000},"page":"366-371","source":"Crossref","is-referenced-by-count":7,"title":["Pituitary resistance to thyroid hormones: pathophysiology and therapeutic options"],"prefix":"10.1007","volume":"40","author":[{"given":"Satoru","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Shigematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidefumi","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teiji","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhisa","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,29]]},"reference":[{"key":"9538_CR1","first-page":"348","volume":"14","author":"S Refetoff","year":"1993","unstructured":"S. Refetoff, The syndrome of resistance to thyroid hormone. Endocr. Rev. 14, 348\u2013399 (1993)","journal-title":"Endocr. Rev."},{"key":"9538_CR2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1172\/JCI108133","volume":"56","author":"MC Gershengorn","year":"1975","unstructured":"M.C. Gershengorn, B.D. Weintraub, Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of \u201cinappropriate secretion of TSH\u201d. J. Clin. Invest. 56, 633\u2013642 (1975)","journal-title":"J. Clin. Invest."},{"key":"9538_CR3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1010072605757","volume":"1","author":"RE Weiss","year":"2000","unstructured":"R.E. Weiss, S. Refetoff, Resistance to thyroid hormone. Rev. Endocr. Metab. Disord. 1, 97\u2013108 (2000)","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"9538_CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/er.2009-0007","volume":"31","author":"SY Cheng","year":"2010","unstructured":"S.Y. Cheng, J.L. Leonard, P.J. Davis, Molecular aspects of thyroid hormone actions. Endocr. Rev. 31, 139\u2013170 (2010)","journal-title":"Endocr. Rev."},{"key":"9538_CR5","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1210\/jc.2010-2496","volume":"96","author":"T Tagami","year":"2011","unstructured":"T. Tagami, T. Usui, A. Shimatsu, M. Beniko, H. Yamamoto, K. Moriyama, M. Naruse, Aberrant expression of thyroid hormone receptor \u03b2 isoform may cause inappropriate secretion of TSH in a TSH-secreting pituitary adenoma. J. Clin. Endocrinol. Metab. 96, 948\u2013952 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9538_CR6","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1210\/en.2008-1795","volume":"150","author":"MI Chiamolera","year":"2009","unstructured":"M.I. Chiamolera, F.E. Wondisford, Minireview: thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology 150, 1091\u20131096 (2009)","journal-title":"Endocrinology"},{"key":"9538_CR7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI5205","volume":"103","author":"ED Abel","year":"1999","unstructured":"E.D. Abel, H.C. Kaulbach, A. Campos-Barros, R.S. Ahima, M.E. Boers, K. Hashimoto, D. Forrest, F.E. Wondisford, Novel insight from transgenic mice into thyroid hormone resistance and the regulation of thyrotorphin. J. Clin. Invest. 103, 271\u2013279 (1999)","journal-title":"J. Clin. Invest."},{"key":"9538_CR8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0006-8993(00)03094-8","volume":"891","author":"E Mih\u00e1ly","year":"2001","unstructured":"E. Mih\u00e1ly, C. Fekete, G. L\u00e9gr\u00e1di, R.M. Lechan, Hypothalamic dorsomedial nucleus neurons innervate thyrotorpin-releasing hormone-synthesizing neurons in the paraventricular nucleus. Brain Res. 891, 20\u201331 (2001)","journal-title":"Brain Res."},{"key":"9538_CR9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1210\/me.2010-0448","volume":"25","author":"S Lee","year":"2011","unstructured":"S. Lee, B.M. Young, W. Wan, I.H. Chan, M.L. Privalsky, A mechanism for pituitary-resistance to thyroid hormone (PRTH) syndrome: a loss in cooperative coactivator contacts by thyroid hormone receptor (TR)\u03b22. J. Mol. Endocrinol. 25, 1111\u20131125 (2011)","journal-title":"J. Mol. Endocrinol"},{"key":"9538_CR10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1086\/380999","volume":"74","author":"AM Dumitrescu","year":"2004","unstructured":"A.M. Dumitrescu, X.H. Liao, T.B. Best, K. Brockmann, S. Refetoff, A novel syndrome combing thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am. J. Human Genet. 74, 168\u2013175 (2004)","journal-title":"Am. J. Human Genet."},{"key":"9538_CR11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1172\/JCI28253","volume":"117","author":"M Trajkovitc","year":"2007","unstructured":"M. Trajkovitc, T.J. Visser, J. Mittag, S. Horn, J. Lukas, V.M. Darras, G. Raivich, K. Bauer, H. Heuer, Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J. Clin. Invest. 117, 627\u2013635 (2007)","journal-title":"J. Clin. Invest."},{"key":"9538_CR12","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1210\/en.138.8.3359","volume":"138","author":"HM Tu","year":"1997","unstructured":"H.M. Tu, S.W. Kim, D. Salvatore, T. Bartha, G. Legradi, P.R. Larsen, R.M. Lechan, Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138, 3359\u20133368 (1997)","journal-title":"Endocrinology"},{"key":"9538_CR13","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1152\/ajpendo.00571.2004","volume":"289","author":"RP Peeters","year":"2005","unstructured":"R.P. Peeters, A.W. van den Beld, H. Attalki, H. Toor, Y.B. de Rijke, G.G. Kuiper, S.W. Lamberts, J.A. Janssen, A.G. Uitterlinden, T.J. Visser, A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters. AM. J. Physiol. Endocrinol. Metab. 289, E75\u2013E81 (2005)","journal-title":"AM. J. Physiol. Endocrinol. Metab."},{"key":"9538_CR14","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1210\/me.15.12.2137","volume":"5","author":"MJ Schneider","year":"2001","unstructured":"M.J. Schneider, S.N. Fiering, S.E. Pallud, A.F. Parlow, D.L. Germain, V.A. Galton, Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol. Endocrinol. 5, 2137\u20132148 (2001)","journal-title":"Mol. Endocrinol."},{"key":"9538_CR15","unstructured":"JSNP database http:\/\/snp.ims.u-tokyo.ac.jp"},{"key":"9538_CR16","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1089\/thy.2008.0236","volume":"18","author":"HG Sorensen","year":"2008","unstructured":"H.G. Sorensen, W.M. van der Deure, P.S. Hansen, R.P. Peeters, M.M. Breteler, K.O. Kyvik, T.I. Sorensen, L. Hegedus, T.J. Visser, Identification and consequences of polymorphisms in the thyroid hormone receptor alpha and beta genes. Thyroid 18, 1087\u20131094 (2008)","journal-title":"Thyroid"},{"key":"9538_CR17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.beem.2006.11.001","volume":"20","author":"P Beck-Peccoz","year":"2006","unstructured":"P. Beck-Peccoz, L. Persani, D. Calebiro, M. Bonomi, D. Mannavola, I. Campi, Syndromes of hormone resistance in the hypothalamic-pituitary-thyroid axis. Best. Pract. Res. Clin. Endocrinol. Metab. 20, 529\u2013546 (2006)","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"9538_CR18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF03350611","volume":"6","author":"P Beck-Peccoz","year":"1983","unstructured":"P. Beck-Peccoz, G. Piscatelli, M.G. Cattaneo, G. Faglia, Successful treatment of hyperthyroidism due to non-neoplastic pituitary TSH hyperthyroidism with 3, 5, 37-triiodothyroacetic acid (TRIAC). J. Endocrinol. Invest. 6, 217\u2013223 (1983)","journal-title":"J. Endocrinol. Invest."},{"key":"9538_CR19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1210\/jcem-69-2-461","volume":"69","author":"JM Kunitake","year":"1989","unstructured":"J.M. Kunitake, N. Hartman, L.C. Henson, J. Lieberman, D.E. Williams, M. Wong, J.M. Hershman, 3, 5, 3\u2019-triiodothyroacetic acid therapy for thyroid hormone resistance. J. Clin. Endocrinol. Metab. 69, 461\u2013466 (1989)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9538_CR20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF03347890","volume":"14","author":"M Aquilar Diosdado","year":"1991","unstructured":"M. Aquilar Diosdado, L. Escobar-Jimenez, M.L. Fermenez Soto, A. Garcia Curie, F. Escobar-Jimenez, Hyperthyroidism due to familial pituitary resistance to thyroid hormone: successful control with 3, 5, 3\u2019triiodothyroacetic associated to propranolol. J. Endocrinol. Invest. 14, 663\u2013668 (1991)","journal-title":"J. Endocrinol. Invest."},{"key":"9538_CR21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1210\/mend-4-2-227","volume":"4","author":"PA Schueler","year":"1990","unstructured":"P.A. Schueler, H.L. Schwartz, K.A. Strait, C.N. Mariash, J.H. Oppenheimer, Binding of 3, 5, 3\u2019-triiodothyronine (T3) and its analogs to the in vitro translational products of c-erbA protooncogenes: differences in the affinity of the \u03b1- and \u03b2-forms for the acetic acid analog and failure of the human testis and kidney \u03b1-2 products to bind T3. Mol. Endocrinol. 4, 227\u2013234 (1990)","journal-title":"Mol. Endocrinol."},{"key":"9538_CR22","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/jc.80.7.2033","volume":"80","author":"T Takeda","year":"1995","unstructured":"T. Takeda, S. Suzuki, R.T. Liu, L.J. DeGroot, Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 80, 2033\u20132040 (1995)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9538_CR23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1515\/JPEM.1997.10.5.535","volume":"10","author":"F Darendeliler","year":"1997","unstructured":"F. Darendeliler, F. Bas, Successful therapy with 3, 5, 3\u2019-triiodothyroacetic acid (TRIAC) in pituitary resistance to thyroid hormone. J. Pediatr. Endocrinol. Metab. 10, 535\u2013538 (1997)","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"9538_CR24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1089\/thy.1997.7.775","volume":"7","author":"G Radetti","year":"1997","unstructured":"G. Radetti, L. Persani, G. Molinaro, D. Mannavola, D. Corteiazzi, V.K. Chaterjee, P. Beck-Peccoz, Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance. Thyroid 7, 775\u2013778 (1997)","journal-title":"Thyroid"},{"key":"9538_CR25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1210\/jcem-58-4-731","volume":"58","author":"DR Bajorunas","year":"1984","unstructured":"D.R. Bajorunas, W. Rosner, I.A. Kourides, Use of bromocriptine in a patient with generalized resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 58, 731\u2013735 (1984)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9538_CR26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2265.1988.tb03684.x","volume":"28","author":"PI Salmela","year":"1988","unstructured":"P.I. Salmela, L. Wilde, H. Juustila, A. Ruokon\u00e8n, Effects of thyroid hormones (T4, T3), bromocriptine, and TRIAC on inappropriate TSH hypersecretion. Clin. Endocrinol. 28, 497\u2013507 (1988)","journal-title":"Clin. Endocrinol."},{"key":"9538_CR27","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1210\/jc.75.4.1071","volume":"75","author":"AJ Dulgeroff","year":"1992","unstructured":"A.J. Dulgeroff, M.E. Geffner, S.N. Koyal, M. Wong, J.M. Hershman, Bromocriptine and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 75, 1071\u20131075 (1992)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9538_CR28","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1210\/jcem-67-5-1089","volume":"67","author":"P Hamon","year":"1988","unstructured":"P. Hamon, M. Bovier-Lapierre, M. Robert, D. Peynaud, M. Pugeat, J. Orgiazzi, Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: efficacy of D-thyroxine therapy. J. Clin. Endocrinol. Metab. 67, 1089\u20131093 (1988)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9538_CR29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2265.1990.tb00858.x","volume":"32","author":"F Dorey","year":"1990","unstructured":"F. Dorey, G. Strauch, J.P. Gayno, Thyrotoxicosis due to pituitary resistance to thyroid hormones. Successful control with D thyroxine: a study in three patients. Clin. Endocrinol. 32, 221\u2013228 (1990)","journal-title":"Clin. Endocrinol."},{"key":"9538_CR30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/thy.1992.2.15","volume":"2","author":"ID Schwartz","year":"1992","unstructured":"I.D. Schwartz, B.B. Bercu, Dextrothyroxine in the treatment of generalized thyroid hormone resistance in a boy homozygous for a defect in the T3 receptor. Thyroid 2, 15\u201319 (1992)","journal-title":"Thyroid"},{"key":"9538_CR31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1651-2227.1996.tb14043.x","volume":"85","author":"J Pohlenz","year":"1996","unstructured":"J. Pohlenz, D. Kn\u00f6bl, Treatment of pituitary resistance to thyroid hormone (PRTH) in an 8-year-old boy. Acta Paediatr. 85, 387\u2013390 (1996)","journal-title":"Acta Paediatr."},{"key":"9538_CR32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/thy.2007.0079","volume":"18","author":"B Hamon","year":"2008","unstructured":"B. Hamon, P. Hamon, M. Bovier-Lapierre, M. Pugeat, F. Savagner, P. Rodien, J. Orgiazzi, A child with resistance to thyroid hormone without thyroid hormone receptor gene mutation: a 20-year follow-up. Thyroid 18, 35\u201344 (2008)","journal-title":"Thyroid"},{"key":"9538_CR33","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1515\/JPEM.2009.22.10.971","volume":"22","author":"T Guran","year":"2009","unstructured":"T. Guran, S. Turan, R. Bircan, A. Bereket, 9\u00a0years follow-up of a patient with pituitary resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC). J. Pediatr. Endocrinol. Metab. 22, 971\u2013978 (2009)","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"9538_CR34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1210\/jc.2007-2020","volume":"93","author":"S Refetoff","year":"2008","unstructured":"S. Refetoff, Resistance to thyroid hormone: one of several defects causing reduced sensitivity to thyroid hormone. Nat. Clin. Pract. Endocrinol. Metab. 93, 605\u2013610 (2008)","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"9538_CR35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.endonu.2011.02.001","volume":"58","author":"J Bernal","year":"2011","unstructured":"J. Bernal, Thyroid hormone resistance syndrome. Endocrinol. Nutr. 58, 185\u2013196 (2011)","journal-title":"Endocrinol. Nutr."},{"key":"9538_CR36","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1172\/JCI110854","volume":"71","author":"TJ Visser","year":"1983","unstructured":"T.J. Visser, M.M. Kaplan, J.L. Leonard, P.R. Larsen, Evidence for two pathways of iodothyronine 5\u2019-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism. J. Clin. Invest. 71, 992\u20131002 (1983)","journal-title":"J. Clin. Invest."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-011-9538-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-011-9538-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-011-9538-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:56:32Z","timestamp":1559440592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-011-9538-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,29]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9538"],"URL":"https:\/\/doi.org\/10.1007\/s12020-011-9538-2","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,29]]}}}